Interim Reports

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2018

April 2, 2019 – InDex Pharmaceuticals Holding AB (publ) today publishes the Annual Report for 2018, which is earlier than indicated in the financial calendar. The Annual Report (in the Swedish language) is attached as a PDF and is available on the company’s website,

Read more

InDex Pharmaceuticals Holding AB (publ) interim report January – September 2016

Initial public offering and listing on Nasdaq First North Stockholm Period July – September 2016  Revenues amounted to MSEK 0.0 (0.0)  Operating result amounted to MSEK -6.6 (-7.5)  Result after tax amounted to MSEK -7.4 (-7.2), corresponding to SEK -0.25 per share (-0.24) before and after dilution  Cas...

Read more